March 20 (Reuters) - Cipla Ltd:
* CLARIFIES ON NEWS ITEM REGARDING U.S. FDA OBSERVATIONS FOR CO’S GOA UNIT
* SAYS RECEIVED CERTAIN OBSERVATIONS WHICH ARE PROCEDURAL IN NATURE
* SAYS FDA CONDUCTED PRODUCT SPECIFIC PRE-APPROVAL INSPECTION AT GOA PLANT IN JANUARY 2018
* SAYS "AT THIS STAGE, WE DO NOT FORESEE ANY IMPACT ON OTHER PRODUCTS BEING MANUFACTURED/FILED FROM PLANT" Source text - bit.ly/2u83eKg Further company coverage: